GSK, VirnetX, Tivo, LVMH, Kolon: Intellectual Property

ViiV Healthcare Ltd., a joint venture of GlaxoSmithKline Plc and two other drugmakers, plans to license pediatric versions of its HIV drug abacavir to a patent-sharing body backed by the United Nations to improve children’s access to treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.